NCT05565378
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05565378
Title A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | TUR | POL | NLD | ITA | HUN | GRC | GBR | FRA | FIN | ESP | DEU | BRA | BEL | ARG

Facility Status City State Zip Country Details
GSK Investigational Site Plantation Florida 33322 United States Details
GSK Investigational Site Albuquerque New Mexico 87131 United States Details
GSK Investigational Site Chattanooga Tennessee 37404 United States Details
GSK Investigational Site Morgantown West Virginia 26506 United States Details
GSK Investigational Site Buenos Aires C1426ABP Argentina Details
GSK Investigational Site Cipoletti Rio Negro R8324CVE Argentina Details
GSK Investigational Site Ciudad Autonoma de Buenos Aire 1414 Argentina Details
GSK Investigational Site Ciudad Autonoma de Buenos Aire C1426AGE Argentina Details
GSK Investigational Site Florida 1602 Argentina Details
GSK Investigational Site Mar del Plata 7600 Argentina Details
GSK Investigational Site San Juan J5402DIL Argentina Details
GSK Investigational Site Santa Fe 3000 Argentina Details
GSK Investigational Site Wilrijk 2650 Belgium Details
GSK Investigational Site Barretos 14784-400 Brazil Details
GSK Investigational Site Porto Alegre 90610-000 Brazil Details
GSK Investigational Site São Paulo 01246-000 Brazil Details
GSK Investigational Site Vitória 29043-260 Brazil Details
GSK Investigational Site Oulu 90029 Finland Details
GSK Investigational Site Tampere 33520 Finland Details
GSK Investigational Site Turku 20520 Finland Details
GSK Investigational Site Vaasa 65130 Finland Details
GSK Investigational Site Bordeaux 33076 France Details
GSK Investigational Site Caen 14033 France Details
GSK Investigational Site Marseille 13009 France Details
GSK Investigational Site Quimper 29107 France Details
GSK Investigational Site Strasbourg 67091 France Details
GSK Investigational Site Berlin 13125 Germany Details
GSK Investigational Site Essen 45147 Germany Details
GSK Investigational Site Großhansdorf 22927 Germany Details
GSK Investigational Site Heidelberg 69126 Germany Details
GSK Investigational Site Jena 07747 Germany Details
GSK Investigational Site Athens 11528 Greece Details
GSK Investigational Site Haidari - Athens 12462 Greece Details
GSK Investigational Site Larissa 41110 Greece Details
GSK Investigational Site PapagosAthens 115 27 Greece Details
GSK Investigational Site Pylaia Thessaloniki 57001 Greece Details
GSK Investigational Site Thessaloniki 54645 Greece Details
GSK Investigational Site Thessaloniki 57010 Greece Details
GSK Investigational Site Budapest H-1121 Hungary Details
GSK Investigational Site Gyöngyös 3200 Hungary Details
GSK Investigational Site Tatabánya 2800 Hungary Details
GSK Investigational Site Avellino 83100 Italy Details
GSK Investigational Site Bergamo 24125 Italy Details
GSK Investigational Site Florence 50134 Italy Details
GSK Investigational Site Genova 16132 Italy Details
GSK Investigational Site Pisa 57124 Italy Details
GSK Investigational Site Verona 37045 Italy Details
GSK Investigational Site Chiba 277-8577 Japan Details
GSK Investigational Site Fukuoka 812-8582 Japan Details
GSK Investigational Site Hyōgo 673-8558 Japan Details
GSK Investigational Site Kanagawa 241-8515 Japan Details
GSK Investigational Site Osaka 589-8511 Japan Details
GSK Investigational Site Saitama 350-1298 Japan Details
GSK Investigational Site Guadalajara 44280 Mexico Details
GSK Investigational Site San Luis Potosí City 78209 Mexico Details
GSK Investigational Site Enschede 7512 KZ Netherlands Details
GSK Investigational Site Groningen 9728 NZ Netherlands Details
GSK Investigational Site Leeuwarden 8934 AD Netherlands Details
GSK Investigational Site Utrecht 3543 AZ Netherlands Details
GSK Investigational Site Lublin 20-954 Poland Details
GSK Investigational Site Prabuty 82-550 Poland Details
GSK Investigational Site Siedlce 08-110 Poland Details
GSK Investigational Site Gaia 4434-502 Portugal Details
GSK Investigational Site Guimarães 4835-044 Portugal Details
GSK Investigational Site Lisbon 1500-650 Portugal Details
GSK Investigational Site Lisbon 1998-018 Portugal Details
GSK Investigational Site Porto 4200-072 Portugal Details
GSK Investigational Site Cape Town 7570 South Africa Details
GSK Investigational Site Parktown 2193 South Africa Details
GSK Investigational Site Incheon 21565 South Korea Details
GSK Investigational Site Seoul 03080 South Korea Details
GSK Investigational Site Seoul 03722 South Korea Details
GSK Investigational Site Suwon Gyeonggi-do 442-723 South Korea Details
GSK Investigational Site Badajoz 06080 Spain Details
GSK Investigational Site Badalona 08916 Spain Details
GSK Investigational Site Barcelona 08035 Spain Details
GSK Investigational Site Barcelona 08907 Spain Details
GSK Investigational Site Las Palmas de Gran Canar 35016 Spain Details
GSK Investigational Site Madrid 28027 Spain Details
GSK Investigational Site Madrid 28041 Spain Details
GSK Investigational Site Madrid 28046 Spain Details
GSK Investigational Site Málaga 29010 Spain Details
GSK Investigational Site PamplonaNavarra 28027 Spain Details
GSK Investigational Site Pozuelo de AlarcOn Madr 28223 Spain Details
GSK Investigational Site Valencia 46009 Spain Details
GSK Investigational Site Valencia 46026 Spain Details
GSK Investigational Site Bangkok 10210 Thailand Details
GSK Investigational Site Chiang Mai 50200 Thailand Details
GSK Investigational Site Kho Hong Hat Yai 90110 Thailand Details
GSK Investigational Site Khon Kaen 40002 Thailand Details
GSK Investigational Site Pathum Thani 12120 Thailand Details
GSK Investigational Site Samsun Atakum 55200 Turkey (Türkiye) Details
GSK Investigational Site Ankara 06680 Turkey (Türkiye) Details
GSK Investigational Site Ankara 06800 Turkey (Türkiye) Details
GSK Investigational Site Antalya 07070 Turkey (Türkiye) Details
GSK Investigational Site Istanbul 34214 Turkey (Türkiye) Details
GSK Investigational Site Abu Dhabi 51900 United Arab Emirates Details
GSK Investigational Site Abu Dhabi United Arab Emirates Details
GSK Investigational Site Middlesbrough TS4 3BW United Kingdom Details
GSK Investigational Site Middlesex HA6 2RN United Kingdom Details
GSK Investigational Site Wolverhampton WV10 0QP United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field